AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 25099464
Drug: Soy dietary
RxNorm normalized name: soy acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy dietary supplement (isoflavone 90mg)
Trial: 25099464
Drug: Low-dose hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low-dose hormone therapy (estradiol 1 mg plus noretisterone 0.5 mg)
Trial: 22285123
Drug: GIK infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GIK infusion (500 mL of dextrose in water (DW) 10% + 40 U of regular insulin + 40 mEq of KCl, and 2 g of MgSO(4)) at a rate of 1 mL/kg/h for 10 hours preoperatively and until the removal of the aortic cross‐clamp
Trial: 22285123
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (half saline solution as placebo with an equivalent infusion rate)
Trial: 7786704
Drug: Intraoperative intra-arterial
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intraoperative intra-arterial fibrinolytic therapy (IIFT) with 250,000 IU of urokinase over 30 minutes
Trial: 2392793
Drug: Pressurised metered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pressurised metered dose inhaler (400 micrograms salbutamol)
Trial: 507163
Drug: 4% pilocarpine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% pilocarpine hydrochloride gel applied at bedtime
Trial: 507163
Drug: 4% pilocarpine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% pilocarpine hydrochloride drops instilled four times daily
Trial: 19403473
Drug: Intranasal mupirocin
RxNorm normalized name: Mupirocin
DrugBank: Mupirocin (DB00410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal mupirocin ointment treatment and sodium hypochlorite (bleach) baths
Trial: 19403473
Drug: Intranasal petrolatum
RxNorm normalized name: Petrolatum
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal petrolatum ointment treatment and plain water baths (placebo)
Trial: 17502459
Drug: Nanoparticular CoQ(10)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nanoparticular CoQ(10) (100 mg 3 times a day) for 3 months
Trial: 17181889
Drug: NaFeEDTA capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NaFeEDTA capsule containing 60 mg Fe once per week for IDs and IDE groups, three times per week for IDA group for nine consecutive weeks
Trial: 17181889
Drug: NaFeEDTA capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NaFeEDTA capsule containing 60 mg Fe
Trial: 11890101
Drug: Calcium supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium supplementation (1,200 mg daily for 11 months)
Trial: 11890101
Drug: Decaffeinated green
RxNorm normalized name: (-)-EPIGALLOCATECHIN-3-O-GALLATE (EGCG) (CONSTITUENT OF POWDERED DECAFFEINATED GREEN TEA EXTRACT) [DSC]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Decaffeinated green tea (DGT) (5 mg daily for 12 months)
Trial: 1973969
Drug: Transdermal hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal hormone replacement therapy - continuous oestradiol 17‐beta 0.05 mg daily, with norethisterone acetate 0.25 mg daily for 14 of each 28 days
Trial: 1973969
Drug: Oral hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral hormone replacement therapy - continuous conjugated equine oestrogens 0.625 mg daily, with dl‐norgestrel 0.15 mg daily for 12 of each 28 days
Trial: 1014769
Drug: Hyoscine‐N‐butyl‐bromide (HBB)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyoscine‐N‐butyl‐bromide (HBB) sugar‐coated tablets (5 X 20 mg/daily)
Trial: 25479022
Drug: Perindopril 3.5 mg/amlodipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril 3.5 mg/amlodipine 2.5 mg
Trial: 25479022
Drug: Perindopril 3.5
RxNorm normalized name: AMLODIPINE 2.5MG/PERINDOPRIL 3.5MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril 3.5 mg
Trial: 21456305
Drug: Daily oral
RxNorm normalized name: GEMTESA 75 MG Once-Daily Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily oral iron supplement (200 mg ferrous sulfate) for two months
Trial: 15867047
Drug: Morphine infusions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine infusions
Trial: 15867047
Drug: Morphine doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine doses before intubation and at 25 to 72 hours
Trial: 10326317
Drug: Rocking bed
RxNorm normalized name: edible rock crab preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocking bed therapy
Trial: 7549814
Drug: Lowering fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lowering fat consumption to 20% of daily calories
Trial: 1790545
Drug: Trimethoprim and
RxNorm normalized name: Trimethoprim and derivatives
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim and rifampin (TMP/R) 20 mg/kg/day
Trial: 1790545
Drug: Ampicillin (AMP)
RxNorm normalized name: Ampicillin
DrugBank: Ampicillin (DB00415)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ampicillin (AMP) 150 mg/kg/day
Trial: 31287890
Drug: Pre-hatch egg
RxNorm normalized name: EGG
DrugBank: Egg (DB10529)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-hatch egg weight (increased from 47.0 to 54.0 g)
Trial: 28412230
Drug: Standard care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard care plus a multi-modal oral health promotion program (Oral Health 4 Life) integrated within the quitline services
Trial: 21708838
Drug: 0.40 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.40 g/kg of alcohol
Trial: 21708838
Drug: 0.13 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.13 g/kg of alcohol
Trial: 19246474
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg of reboxetine (selective NE reuptake inhibitor)
Trial: 19699148
Drug: therapeutic CPAP
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: therapeutic CPAP (tCPAP) after one treatment night
Trial: 11563806
Drug: High-Intensity (HI)
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-Intensity (HI) group: NRT, 4 advice and education sessions, and 12 weeks of individualized cognitive-behavioral therapy
Trial: 7869999
Drug: Psyllium seeds
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psyllium seeds (3 times 3.25 g daily)
Trial: 7869999
Drug: Wheat bran
RxNorm normalized name: Wheat bran
DrugBank: Wheat bran (DB10685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat bran (3 times 7 g daily)
Trial: 2971403
Drug: Clodronate (Cl2MDP)
RxNorm normalized name: Clodronic acid
DrugBank: Clodronic acid (DB00720)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clodronate (Cl2MDP) 1.6 g/day
Trial: 24075051
Drug: ASC-enriched fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASC-enriched fat grafts (20×10^6 cells per mL fat)
Trial: 21411557
Drug: Denosumab (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denosumab (60 mg s.c. every 6 months)
Trial: 19146606
Drug: Topical antioxidant
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical antioxidant mixture containing vitamin C, ferulic acid, and phloretin
Trial: 14636464
Drug: Adenosine (3,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adenosine (3, 6, and 12 mg intravenous bolus doses)
Trial: 14636464
Drug: Verapamil (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (5 mg or additional 5 mg intravenously)
Trial: 8854770
Drug: High-dose intraarterial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose intraarterial chemotherapy with percutaneous hepatic venous isolation and charcoal hemoperfusion (HVI.CHP)
Trial: 8854770
Drug: Conventional intraarterial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional intraarterial chemotherapy (group S)
Trial: 1615378
Drug: Intravenous nicardipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous nicardipine 0.03 mg/kg/h
Trial: 1615378
Drug: Intravenous nicardipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous nicardipine 0.08 mg/kg/h
Trial: 1615378
Drug: Intravenous nicardipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous nicardipine 0.11 mg/kg/h
Trial: 1615378
Drug: Intravenous nicardipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous nicardipine 0.15 mg/kg/h
Trial: 1615378
Drug: Oral nicardipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral nicardipine 90‐120 mg
Trial: 6380436
Drug: Transfer factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transfer factor (1 ml extracted from the blood of normal individuals, administered starting 1 month postoperatively and at 3-month intervals)
Trial: 6380436
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no transfer factor treatment)
Trial: 27642077
Drug: NK1R antagonist
RxNorm normalized name: Interleukin-1 receptor antagonist anakinra
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: NK1R antagonist (GR205171, 5mg)
Trial: 24290749
Drug: Percutaneous hepatic
RxNorm normalized name: hepatitis nosodes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous hepatic perfusion (PHP) with venovenous bypass circuit and hemofiltration, receiving hepatic intra-arterial melphalan, 3 mg/kg for 30 minutes with 60 minutes of hemofiltration
Trial: 15060495
Drug: Simulated pulpal
RxNorm normalized name: bisacodyl
DrugBank: Bisacodyl (DB09020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simulated pulpal pressure with Superbond C&B adhesive luting agent
Trial: 15060495
Drug: No simulated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No simulated pulpal pressure with Superbond C&B adhesive luting agent
Trial: 11521696
Drug: Short-term topical
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term topical prednisolone acetate 1% (0-6 months)
Trial: 11521696
Drug: Long-term topical
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term topical prednisolone acetate 1% (0-12 months)
Trial: 30341095
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (400 μg) and vitamin B12 (500 μg) supplementation
Trial: 25168768
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of tetanus-diphtheria vaccine
Trial: 25168768
Drug: Subcutaneous injection
RxNorm normalized name: EPINEPHRINE 0.3 mg SUBCUTANEOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous injection of tetanus-diphtheria vaccine
Trial: 17468196
Drug: Testosterone (sustanon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone (sustanon 200 mg)
Trial: 10511068
Drug: Orlistat (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orlistat (120 mg) three times a day with meals for 1 year
Trial: 7589043
Drug: 200 mg.day-1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg.day-1 bezafibrate
Trial: 7589043
Drug: 400 mg.day-1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg.day-1 bezafibrate
Trial: 7589043
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (probucol + bezafibrate)
Trial: 84263
Drug: Chlorpromazine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpromazine (1 mg/kg intramuscularly or 1 mg/kg orally)
Trial: 28303842
Drug: Pinaverium bromide
RxNorm normalized name: pinaverium bromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pinaverium bromide (100 mg, three times a day) one day before examination combined with scopolamine butylbromide (20 mg) 10 min before colonoscopy (Group A)
Trial: 28303842
Drug: Pinaverium bromide
RxNorm normalized name: pinaverium bromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pinaverium bromide alone on the day of colonoscopy (100 mg, three times a day) (Group B0)
Trial: 28303842
Drug: Pinaverium bromide
RxNorm normalized name: pinaverium bromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pinaverium bromide alone one day before colonoscopy (100 mg, three times a day) (Group B1)
Trial: 28303842
Drug: Pinaverium bromide
RxNorm normalized name: pinaverium bromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pinaverium bromide alone two days before colonoscopy (100 mg, three times a day) (Group B2)
Trial: 28303842
Drug: Scopolamine butylbromide
RxNorm normalized name: Scopolamine butylbromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scopolamine butylbromide alone (20 mg) before colonoscopy (Group C)
Trial: 25726210
Drug: Chia flour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chia flour (35 g/day)
Trial: 15310350
Drug: Oral celecoxib
RxNorm normalized name: Celecoxib
DrugBank: Celecoxib (DB00482)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral celecoxib 200 mg
Trial: 12406587
Drug: 11 g
RxNorm normalized name: PSMA-11 Ga 68
DrugBank: Gallium Ga-68 gozetotide (DB16019)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 11 g elderberry concentrate (containing 1.9 g of anthocyanins) diluted with water
Trial: 12406587
Drug: 11 g
RxNorm normalized name: PSMA-11 Ga 68
DrugBank: Gallium Ga-68 gozetotide (DB16019)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 11 g elderberry concentrate (containing 1.9 g of anthocyanins) diluted with 30 g sucrose
Trial: 9832096
Drug: Low-dose isoproterenol
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose isoproterenol (3- and 5-microg/min)
Trial: 9832096
Drug: Sublingual nitroglycerin
RxNorm normalized name: nitroglycerin Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual nitroglycerin (after drug-free state)
Trial: 9832096
Drug: High-dose isoproterenol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose isoproterenol infusion and nitroglycerin
Trial: 7661125
Drug: Low meat
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low meat with mineral supplements diet (LS)
Trial: 2788004
Drug: Enteric coated
RxNorm normalized name: Mesasal Enteric Coated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteric coated sodium salicylate 4.8 g daily
Trial: 2788004
Drug: Enteric coated
RxNorm normalized name: Mesasal Enteric Coated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteric coated aspirin 4.8 g daily
Trial: 388397
Drug: Tienilic acid
RxNorm normalized name: Tienilic acid
DrugBank: Tienilic acid (DB04831)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tienilic acid (250 mg, increased to 500 mg if warranted)
Trial: 388397
Drug: Hydrochlorothiazide (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (50 mg, increased to 100 mg if warranted)
Trial: 28915304
Drug: HPV vaccine
RxNorm normalized name: HPV vaccine 9-valent/PF 0.5 mL INTRAMUSC VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPV vaccine initiation in 2010
Trial: 28915304
Drug: HPV vaccine
RxNorm normalized name: HPV vaccine 9-valent/PF 0.5 mL INTRAMUSC VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPV vaccine initiation in 2008
Trial: 28915304
Drug: HPV vaccine
RxNorm normalized name: HPV vaccine 9-valent/PF 0.5 mL INTRAMUSC VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPV vaccine initiation in 2009
Trial: 28915304
Drug: HPV vaccine
RxNorm normalized name: HPV vaccine 9-valent/PF 0.5 mL INTRAMUSC VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPV vaccine completion in 2010
Trial: 28915304
Drug: HPV vaccine
RxNorm normalized name: HPV vaccine 9-valent/PF 0.5 mL INTRAMUSC VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPV vaccine completion in 2008
Trial: 28915304
Drug: HPV vaccine
RxNorm normalized name: HPV vaccine 9-valent/PF 0.5 mL INTRAMUSC VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPV vaccine completion in 2009
Trial: 23379490
Drug: Intravenous alfacalcidol
RxNorm normalized name: alfacalcidol
DrugBank: Alfacalcidol (DB01436)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous alfacalcidol once weekly
Trial: 15458450
Drug: Fluvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin (40 mg and 80 mg daily)
Trial: 10657833
Drug: Intravenous cyclophosphamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cyclophosphamide therapy (IVCY) for 36 months
Trial: 8841155
Drug: Itraconazole 200
RxNorm normalized name: itraconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole 200 mg taken simultaneously with triazolam
Trial: 8841155
Drug: Itraconazole 200
RxNorm normalized name: itraconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole 200 mg taken 3 hours before triazolam
Trial: 8841155
Drug: Itraconazole 200
RxNorm normalized name: itraconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole 200 mg taken 12 hours before triazolam
Trial: 8841155
Drug: Itraconazole 200
RxNorm normalized name: itraconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole 200 mg taken 24 hours before triazolam
Trial: 31434161
Drug: Barcode-assisted medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Barcode-assisted medication administration (BCMA) system
Trial: 29798256
Drug: Cetylpyridinium Chloride
RxNorm normalized name: Cetylpyridinium Chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetylpyridinium Chloride Buccal Tablets
Trial: 23886754
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no GH treatment initially)
Trial: 21276660
Drug: Early excision
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early excision and grafting (E&G)
Trial: 16412989
Drug: Vitamin therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin therapy (oral folic acid, B‐12, and pyridoxine) for 3 months
Trial: 12633007
Drug: Mailing guidelines
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mailing guidelines targeted to a patient starting treatment
Trial: 10695290
Drug: Influenza vaccine
RxNorm normalized name: Influenza vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Influenza vaccine (administered once or twice depending on prior vaccination status)
Trial: 31178259
Drug: Atorvastatin 80
RxNorm normalized name: atorvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 80 mg (oral tablets), administered 12 and 2 hours preoperatively, and on the 2nd, 3rd, 4th, and 5th postoperative days
Trial: 31178259
Drug: Atorvastatin 80
RxNorm normalized name: atorvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 80 mg (oral tablets)
Trial: 25862770
Drug: Ultrasonophoresis with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasonophoresis with standard treatment (supervised exercises and cryotherapy)
Trial: 25862770
Drug: Iontophoresis with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iontophoresis with standard treatment (supervised exercises and cryotherapy)
Trial: 25862770
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (supervised exercises and cryotherapy) with placebo iontophoresis and placebo ultrasonophoresis
Trial: 22207250
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy (experimental group listening to recorded music)
Trial: 20206790
Drug: etravirine 200
RxNorm normalized name: etravirine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: etravirine 200 mg BID with food for 7 days and a morning dose on day 8
Trial: 17827960
Drug: Supervised toothbrushing
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Supervised toothbrushing once a day at school with 1,000 ppm fluoride toothpaste and a home support package encouraging twice-daily toothbrushing
Trial: 12452235
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg epidural morphine
Trial: 10510952
Drug: Metformin (850
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (850 mg b.d.)
Trial: 6758825
Drug: Propranolol (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (80 mg twice daily for 2 weeks)
Trial: 28328847
Drug: Topical 0.15%
RxNorm normalized name: menthol topical 0.15% topical lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 0.15% isopropyl unoprostone (IU) used 3 times a day for 54 weeks
Trial: 23317926
Drug: Whey protein
RxNorm normalized name: Whey protein
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whey protein drink (20 g whey protein, 20 g carbohydrates)
Trial: 23317926
Drug: Milk protein
RxNorm normalized name: Milk protein
DrugBank: Casein (DB10516)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk protein drink (20 g milk protein, 20 g carbohydrates)
Trial: 23317926
Drug: Carbohydrate drink
RxNorm normalized name: Ensure Pre-Surgery Clear Carbohydrate Drink (Strawberry)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate drink (40 g carbohydrates)
Trial: 21501517
Drug: IFNβ‐1a 22
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFNβ‐1a 22 mcg (low dose, LD)
Trial: 21501517
Drug: IFNβ‐1a 44
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFNβ‐1a 44 mcg (high dose, HD)